$27.240
-1.367 (-5.02%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
KMTS-Prognose durch Analyse ähnlicher Charts
Alphio's KMTS stock price prediction model matches the current Kestra Medical Technologies Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $27.68 (+1.60%). The 1-week path is $28.50 (+4.63%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Kestra Medical Technologies Ltd-Aktien kaufen?
Kestra Medical Technologies is a good buy right now due to its significant revenue growth of 60% year-over-year, increasing from $19.37 million to $30.97 million, and a gross margin improvement to 56.5%, which is up over 10 percentage points year-over-year. The main risk is the widening net loss of $44.09 million for Q1 2027, which could impact investor sentiment.
KMTS schloss am Friday bei $27.24, nachdem der Kurs -5.02% fallen
Kestra Medical Technologies Ltd (KMTS) last closed at $27.24, losing -5.02%. These facts feed the 1-day and 1-week KMTS price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Kestra Medical Technologies Ltd (KMTS) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf KMTS am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für KMTS
Historically the probability of a positive October return for KMTS is 100.00%. October offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.